EEA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.079800E-01
Normal-vs-Stage2
4.849600E-01
Normal-vs-Stage3
1.490760E-01
Normal-vs-Stage4
9.664800E-01
Stage1-vs-Stage2
6.365000E-01
Stage1-vs-Stage3
5.916200E-02
Stage1-vs-Stage4
7.452200E-01
Stage2-vs-Stage3
1.016980E-04
Stage2-vs-Stage4
4.564600E-01
Stage3-vs-Stage4
1.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.265200E-01
Normal-vs-AfricanAmerican
7.854600E-01
Normal-vs-Asian
1.188830E-01
Caucasian-vs-AfricanAmerican
3.153200E-01
Caucasian-vs-Asian
2.142200E-01
AfricanAmerican-vs-Asian
1.601770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.893600E-01
Normal-vs-Female
4.982600E-01
Male-vs-Female
8.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.124400E-01
Normal-vs-Age(41-60Yrs)
8.872600E-01
Normal-vs-Age(61-80Yrs)
3.317200E-01
Normal-vs-Age(81-100Yrs)
1.570370E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.210000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.411400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.309200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.440000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.130400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.325000E-01
Normal-vs-Daily Drinker
1.012240E-01
Normal-vs-Weekly Drinker
2.502400E-01
Normal-vs-Occasional Drinker
5.920200E-01
Normal-vs-Social Drinker
8.760000E-01
Non Drinker-vs-Daily Drinker
3.567200E-01
Non Drinker-vs-Weekly Drinker
8.314200E-01
Non Drinker-vs-Occasional Drinker
3.434000E-01
Non Drinker-vs-Social Drinker
3.046200E-01
Daily Drinker-vs-Weekly Drinker
3.087800E-01
Daily Drinker-vs-Occasional Drinker
1.077620E-01
Daily Drinker-vs-Social Drinker
1.435950E-01
Weekly Drinker-vs-Occasional Drinker
5.302800E-01
Weekly Drinker-vs-Social Drinker
3.804600E-01
Occasional Drinker-vs-Social Drinker
6.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.330800E-01
Normal-vs-Grade 2
1.433160E-01
Normal-vs-Grade 3
1.597620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.716800E-01
Grade 1-vs-Grade 3
7.856200E-01
Grade 1-vs-Grade 4
2.330800E-01
Grade 2-vs-Grade 3
5.558800E-01
Grade 2-vs-Grade 4
1.433160E-01
Grade 3-vs-Grade 4
1.597620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.353600E-01
Normal-vs-NonDiabetic
3.606400E-01
Diabetic-vs-NonDiabetic
9.821800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.906500E-02
Normal-vs-NoPancreatitis
4.245400E-01
Pancreatitis-vs-NoPancreatitis
5.569700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.541800E-01
Normal-vs-N1
5.173600E-01
N0-vs-N1
7.098000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.997200E-01
Normal-vs-TP53-NonMutant
7.017600E-01
TP53-Mutant-vs-TP53-NonMutant
2.149400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
